Surgical Treatment of Peri-implantitis

• Status: Active, not recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this randomized controlled study is to evaluate the outcome of surgical treatment of peri-implantitis with and without the use of a bone substitute graft covered by a collagen membrane. There will be a follow up period of 12 months. Outcome measures will include assessments of inflammation, probing depth, recession, radiological parameters and PROMs.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: The University of Western Australia
• Collaborator: Osteology Foundation

Criteria

Inclusion Criteria:

Presence of ≥ 1 implant with a probing depth (PD) ≥ 5 mm with bleeding and/or suppuration (SUP) on probing, and peri-implant bone loss ≥ 3mm with an intraosseous defect component

Exclusion Criteria:

• Smokers > 10 cigarettes per day

• Patients with uncontrolled diabetes mellitus

• Pregnant or lactating women (self reported)

• Patients with a systemic illness that preclude them from oral surgery

• Patients with an allergy to amoxicillin or metronidazole or chlorhexidine.

• Patients requiring antibiotic prophylaxis and Patients who have taken antibiotics in the past 3 months